Critical Care Management of Lung Fibrosis, Review Article

Abdullah Rashed Alharbi, Bashayr marzoug alotaibi
{"title":"Critical Care Management of Lung Fibrosis, Review Article","authors":"Abdullah Rashed Alharbi, Bashayr marzoug alotaibi","doi":"10.47363/jmhc/2023(5)233","DOIUrl":null,"url":null,"abstract":"Pulmonary fibrosis or lung fibrosis have been one of the major complications associated with the lungs that lead to deprived quality of life and increased suffering in individuals who stop It leads an individual towards inability to involve in daily activities as well as sustain complications such as severe cuffs and shortness of breath which often leads to life-threatening condition if proper treatment and management procedures are not incorporated. It has also been found that due to the COVID-19 pandemic, the risk of sustaining pulmonary fibrosis in patients has increased which has led to increased complications and deprived health. Focusing on this evidence, the following research aims on evaluating critical care management and treatment procedures identified and acknowledged within the healthcare setting against pulmonary fibrosis or lung fibrosis. Critical care management must focus on limiting the progression of the condition, ensuring better lung functioning and health as well as improving quality of life. Concentrating on the rising issue, the following research study conducted a literature review using evidence from 5 selected articles and journals. The evidence obtained from the articles highlights that anti-fibrotic therapy such as Pirfenidone, pulmonary rehabilitation, and physical activity sustains the potential role of managing and enhancing health and quality of life in suffering patients. Apart from these identified management procedures, there is a vast range of strategies that can be incorporated into daily life by the patients to sustain better recovery from the condition and lead a healthy life with minimal risk of progression and prognosis of the condition.","PeriodicalId":93468,"journal":{"name":"Journal of medicine and healthcare","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of medicine and healthcare","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47363/jmhc/2023(5)233","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Pulmonary fibrosis or lung fibrosis have been one of the major complications associated with the lungs that lead to deprived quality of life and increased suffering in individuals who stop It leads an individual towards inability to involve in daily activities as well as sustain complications such as severe cuffs and shortness of breath which often leads to life-threatening condition if proper treatment and management procedures are not incorporated. It has also been found that due to the COVID-19 pandemic, the risk of sustaining pulmonary fibrosis in patients has increased which has led to increased complications and deprived health. Focusing on this evidence, the following research aims on evaluating critical care management and treatment procedures identified and acknowledged within the healthcare setting against pulmonary fibrosis or lung fibrosis. Critical care management must focus on limiting the progression of the condition, ensuring better lung functioning and health as well as improving quality of life. Concentrating on the rising issue, the following research study conducted a literature review using evidence from 5 selected articles and journals. The evidence obtained from the articles highlights that anti-fibrotic therapy such as Pirfenidone, pulmonary rehabilitation, and physical activity sustains the potential role of managing and enhancing health and quality of life in suffering patients. Apart from these identified management procedures, there is a vast range of strategies that can be incorporated into daily life by the patients to sustain better recovery from the condition and lead a healthy life with minimal risk of progression and prognosis of the condition.
肺纤维化的重症监护管理,综述文章
肺纤维化或肺纤维化是与肺部相关的主要并发症之一,会导致停下来的人生活质量下降,痛苦增加。它会导致一个人无法参与日常活动,并持续出现严重的手铐和呼吸急促等并发症,如果适当的话,这往往会导致危及生命的情况未纳入治疗和管理程序。还发现,由于新冠肺炎大流行,患者持续肺纤维化的风险增加,导致并发症增加和健康状况恶化。基于这一证据,以下研究旨在评估医疗环境中确定和认可的重症监护管理和治疗程序,以对抗肺纤维化或肺纤维化。重症监护管理必须专注于限制病情进展,确保更好的肺功能和健康,并提高生活质量。以下研究利用5篇精选文章和期刊中的证据,对这一新兴问题进行了文献综述。从这些文章中获得的证据强调,抗纤维化治疗,如吡非尼酮、肺部康复和体育活动,在管理和提高患者健康和生活质量方面发挥着潜在作用。除了这些已确定的管理程序外,患者还可以将各种策略纳入日常生活,以维持更好的病情恢复,并在病情进展和预后风险最小的情况下过上健康的生活。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信